SavedAdd your journal

Journals / Anestezi Dergisi / 2000 / Cilt: 8 - Sayı: 2

Sevoflurane and malign hyperthermia: Two pediatric cases

Sevofluran ve malign hipertermi: İki pediyatrik olgu nedeniyle

Öztin Cemile ÖĞÜN
Selmin ÖKESLİ
ATEŞ DUMAN
Pages
129–137
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The cases were evaluated postoperatively according to North American Malignant Hyperthermia Registry clinical grading scale.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, malign hyperthermia was presented in which sevoflurane, succinylcholine and opioid induction were used in 11 month and 2 years old babies.
📊
Key Findings & Data:Both cases recovered without sequeles after symptomatic treatment and intensive care unit observation.
💡
Conclusion & Impact:The cases were evaluated postoperatively according to North American Malignant Hyperthermia Registry clinical grading scale.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cerrahi işlemler · operatif · Malign hipertermi

Abstract

In this study, malign hyperthermia was presented in which sevoflurane, succinylcholine and opioid induction were used in 11 month and 2 years old babies. Both cases recovered without sequeles after symptomatic treatment and intensive care unit observation. The cases were evaluated postoperatively according to North American Malignant Hyperthermia Registry clinical grading scale.

Özet

Bu çalışmada; sevofluran, süksinilkolin ve opioid indüksiyonu yapılan yarık damak-dudak operasyonu geçiren biri 11 aylık diğeri 2 yaşında iki malign hipertermi olgusu sunuldu. Semptomatik tedavi uygulanan ve yoğun bakımda takip edilen her iki olgu sekelsiz iyileşti. Olgular Kuzey Amerika Malign Hipertemi Kayıt Komisyonunca belirlenen klinik puanlama skalasına göre postoperatif değerlendirildiler.

🔖

Cite This Article

ÖĞÜN, Ö. C., ÖKESLİ, S., DUMAN, A. (2000). Sevoflurane and malign hyperthermia: Two pediatric cases. Anestezi Dergisi, Cilt: 8 - Sayı: 2, 129–137. https://ajindex.com/articles/355521

References (18)

  1. Deııborough MA, Foster JFA, Lovely RRH, Maplestone PA, Villiers JD. Anaesthetic deaths in a family. Br J Anaesth 1962; 34: 395-6
  2. Britt BA. Kalow W. Malignant hyperthermia. Can Anaesth Soc J 1985; 32: 666-77
  3. Gronert GA, Antognini JF. Malignant Hyperthermia. In: Miller RD, Anesthesia, New York, Churchill Livingstone 1994: 1075-1093
  4. Sewall K, Flowerdew RMM, Bromberger P. Severe muscular rigidity at birth: Malignant hyperthermia svndrome? Can Anaesth Soc J 1980; 27: 279
  5. Sigg D, Censier K, Urwyler A. Effects of halothane, enflurane, isoflurane, desflurane, sevoflurane on myoplasmic calcium contentration in skeleteal muscle. Br J Anaesth 1997; 79: 54
  6. Maeda H, Iranami H, Hatano Y. Delayed recovery from muscle weakness due to malignant hyperthermia during sevoflurane anesthesia. Anesthesiology 1997; 87: 452-6
  7. Claussen D, Wutting K, Freudenberg J, Claussen A. Maligne Hyperthermia und sevofluran. Eine Kasuistik. Anashesiol Intensivmed Notfallmed Schmerzther 1997; 32: 641-4
  8. Kanaya N, Nakayama M, Nakae Y, Kobayashi I, Tsuchidea H, Namiki A. Hyperthermia during sevoflurane anaesthesia in arthrogypozis multiplex congenita with central nervous system dysfunction. Paediatr Anaesth 1996; 6: 428-9
  9. Komatsu H, Enzan K, Suzuki M. A case of abortive malignant hyperthermia during funnel chest surgery. Masui 1993: 42: 1053-5
  10. Ochiai R, Toyoda Y, Nishio I, et al. Possible association of malignant hyperthermia with sevoflurane anesthesia. Anesth Analg 1992;74:616-8
  11. Otsuka H, Komura Y, Mayumi T, Yamamura T, Kemmotsu O, Mukaida K. Malignant hyperthermia during sevoflurane anesthesia with central core disease. Anesthesiology 1991: 75: 699-701
  12. Wackym PA, Dubrow TJ, Abdul-Rasool IH, Lesavoy MA. Malignant hyperthermia in plastic surgery. Plast Reconstr Surg 1988; 82: 878-82
  13. Wackym PA, Abdul-Rasool IH. Prospective management malignant hyperthermia in the otolaryngological patient. J Laryngol Otol 1988; 102: 513-6
  14. Smilh RJ. Preoperative assessment of risk factors. Br J Anaesth 1988: 60: 317-9
  15. Kaus SJ. Rockoff MA. Malignant hyperthermia. Anesthesia Clinics of North America (Pediat Anesth) 1994; 41: 221-37
  16. Strazis KP, Fox AW. Malignant hyperthermia: A review of puplished cases. Anesth Analg 1993;77: 297-304
  17. Christiaens F, Gebts E, Ditaese J, Camu F. Malignant hyperthermia suggestive hypermetabolic syndrome at emergence from anesthesia. Acta Anaesthesiol Belg 1995; 46: 93-7
  18. Allen GC, Brubaker CI. Human malignant hy